Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
- 1 November 2001
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 358 (9294), 1665-1667
- https://doi.org/10.1016/s0140-6736(01)06709-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Integrating antenatal Downʼs syndrome screeningCurrent Opinion in Obstetrics and Gynecology, 2001
- Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.Human Reproduction, 2000
- Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucencyPrenatal Diagnosis, 1999
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Letter. Correct estimation of parameters for ultrasound nuchal translucency screeningPrenatal Diagnosis, 1998
- Collagen type VI gene expression in the skin of trisomy 21 fetuses*1Published by Ovid Technologies (Wolters Kluwer Health) ,1998
- Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12--18 weeks and in a trisomy 16 mouseBrain Structure and Function, 1998
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- Birth prevalence of down's syndrome in England and WalesPrenatal Diagnosis, 1991